First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved...

A new Nature Genetics study combines spatial transcriptomics and lineage tracing to map how lung tumor subclones expand, reshape their...

Australian researchers have shown that blocking the BRN2 transcription factor reverses anoikis resistance in melanoma cells and sensitizes them to...

A new glycoproteomic analysis shows that protein-residual N-glycosylation of extracellular matrix proteins marks a myCAF-enriched stromal state in pancreatic ductal...

A ten-center international study finds that direct camera-guided inspection of the bile ducts reliably distinguishes cancer from benign disease, with...

A new review proposes a Dynamic Precision Oncology framework that monitors pancreatic cancer's evolving resistance mechanisms through longitudinal genomic, liquid...

A new study shows that the natural plant compound p-coumaric acid suppresses liver cancer by disrupting mitochondria, blocking the Nrf2...

A new review in Cancer Cell International details how the tumor suppressor RUNX3 regulates apoptosis, drug efflux, cell cycle control,...

A new Molecular Cancer study reveals how UQCRC2 lactylation and SIRT1-driven mitophagy allow colorectal cancer cells to survive chemotherapy in...

A combined blood-based inflammation and nutrition score strongly predicted survival outcomes in newly diagnosed multiple myeloma patients, improving risk stratification...